MARKET OUTLOOK

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems of the body. SLE symptoms range from general malaise to serious CNS and renal manifestations. Hydroxychloroquine, corticosteroids, and conventional immunosuppressants are the mainstay treatments for SLE. Unfortunately, many patients with SLE fail to respond to these therapies and/or experience significant adverse events. In these patients, clinicians may utilize other available agents, such as the biologics Benlysta (GSK) and Rituxan (Roche; off-label). This content provides manufacturers of current treatments and developers of novel SLE agents with insights into the use of SLE drugs and into the market trends in the SLE space.

 

QUESTIONS ANSWERED

· What patient shares do key therapies and brands garner by line of therapy in newly diagnosed SLE patients? What are the quarterly trends in prescribing among recently treated and newly diagnosed SLE patients?

· How has Benlysta been integrated into the treatment algorithm, and what is its source of business?

· What percentage of SLE patients receive drug therapy within one year of diagnosis, and how quickly? What percentage of patients progress to later lines of therapy within one year of diagnosis?

· What percentage of SLE patients are treated with monotherapy versus combination therapy? What are the most commonly used combinations?

· What are the product-level compliance and persistency rates among drug-treated patients?

PRODUCT DESCRIPTION

Treatment Algorithms: Claims Data Analysis provides detailed, quantitative analysis of the treatment journey and brand usage across lines of therapy and overall using real-world, patient-level claims data so that marketers can accurately assess their source of business, benchmark usage against competitors, and quantify areas of opportunity for their marketed or emerging brand.


Related Reports

Systemic Lupus Erythematosus - Current Treatment - Treatment Algorithms - Claims Data Analysis: Systemic Lupus Erythematosus - Refreshed Dashboard 2021 (US)

MARKET OUTLOOK Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems of the body. SLE symptoms range...

View Details

Systemic Lupus Erythematosus - Landscape & Forecast - Disease Landscape & Forecast

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course,...

View Details

Systemic Lupus Erythematosus | Disease Landscape and Forecast | G7 | 2020

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course, manifestations, and treatment approach can be hig...

View Details

Systemic Lupus Erythematosus - Current Treatment - Detailed, Expanded Analysis: Treatment Algorithms - Claims Data Analysis (US) 2021

MARKET OUTLOOK Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems of the body. SLE symptoms range from general malaise to serio...

View Details